These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 23349017)
1. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs. Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017 [TBL] [Abstract][Full Text] [Related]
2. LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity. Morgan RG; Mortensson E; Legge DN; Gupta B; Collard TJ; Greenhough A; Williams AC Br J Cancer; 2018 Feb; 118(4):558-565. PubMed ID: 29149105 [TBL] [Abstract][Full Text] [Related]
3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
4. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells. Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569 [TBL] [Abstract][Full Text] [Related]
5. 5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis. Dixon SW; Collard TJ; Mortensson EMH; Legge DN; Chambers AC; Greenhough A; Creed TJ; Williams AC Br J Cancer; 2021 Jun; 124(12):1959-1969. PubMed ID: 33785874 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
7. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression. Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070 [TBL] [Abstract][Full Text] [Related]
8. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Fan XS; Wu HY; Yu HP; Zhou Q; Zhang YF; Huang Q Int J Colorectal Dis; 2010 May; 25(5):583-90. PubMed ID: 20195621 [TBL] [Abstract][Full Text] [Related]
9. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339 [TBL] [Abstract][Full Text] [Related]
11. LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma. Vieira GC; Chockalingam S; Melegh Z; Greenhough A; Malik S; Szemes M; Park JH; Kaidi A; Zhou L; Catchpoole D; Morgan R; Bates DO; Gabb PD; Malik K Oncotarget; 2015 Nov; 6(37):40053-67. PubMed ID: 26517508 [TBL] [Abstract][Full Text] [Related]
12. LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway. Chen Q; Cao HZ; Zheng PS Oncotarget; 2014 Oct; 5(19):9092-105. PubMed ID: 25193857 [TBL] [Abstract][Full Text] [Related]
13. Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic? Morgan RG; Mortensson E; Williams AC Br J Cancer; 2018 May; 118(11):1410-1418. PubMed ID: 29844449 [TBL] [Abstract][Full Text] [Related]
14. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells. Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270 [TBL] [Abstract][Full Text] [Related]
15. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance. He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002 [TBL] [Abstract][Full Text] [Related]
16. Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells. Morgan RG; Molnár E; Jones RF; Collard TJ; Lane JD; Greenhough A; Paraskeva C; Williams AC Br J Cancer; 2015 Feb; 112(4):714-9. PubMed ID: 25611300 [TBL] [Abstract][Full Text] [Related]
17. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients. Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924 [TBL] [Abstract][Full Text] [Related]
18. Characterization of LGR5 stem cells in colorectal adenomas and carcinomas. Baker AM; Graham TA; Elia G; Wright NA; Rodriguez-Justo M Sci Rep; 2015 Mar; 5():8654. PubMed ID: 25728748 [TBL] [Abstract][Full Text] [Related]
19. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660 [TBL] [Abstract][Full Text] [Related]
20. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Koo BK; Spit M; Jordens I; Low TY; Stange DE; van de Wetering M; van Es JH; Mohammed S; Heck AJ; Maurice MM; Clevers H Nature; 2012 Aug; 488(7413):665-9. PubMed ID: 22895187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]